Author

J. Schiffer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1

Frequent Co-Authors

M. Prlic· 3 shared E. Duke· 2 shared J. M. Lund· 2 shared V. Dave· 2 shared A. Koehne· 1 shared A. Soerens· 1 shared A. Woodward-Davis· 1 shared C. Teague· 1 shared

Activity by Year

2016-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

M. Prlic

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cervicovaginal tissue residence imprints a distinct differentiation program upon memory CD8 T cells

V. Dave, E. F. Cardozo Ojeda, F. Mair, J. Erickson, A. Woodward-Davis, A. Soerens, A. Koehne, J. Czartoski, C. Teague, N. Potchen, S. Oberle, D. Zehn, J. Schiffer, J. M. Lund, M. Prlic

The paper shows that residence in cervicovaginal tissue shapes CD8 T cell phenotype and function, leading to reduced local immunity and impaired viral control upon secondary challenge.

bioRxiv · Apr 23, 2020 · PreprintImmunology

Elimination of HSV-2 infected cells is mediated predominantly by paracrine effects of tissue-resident T cell derived cytokines

P. Roychoudhury, D. A. Swan, E. Duke, L. Corey, J. Zhu, V. Dave, L. Richert Spuhler, J. M. Lund, M. Prlic, J. Schiffer

The paper shows HSV-2 is controlled by cytokines from tissue-resident T cells, not direct cell killing, even when T-cell numbers are low.

bioRxiv · Apr 18, 2019 · PreprintImmunology

Anti-proliferative therapy for HIV cure: a compound interest approach

D. Reeves, E. Duke, S. Hughes, M. Prlic, F. Hladik, J. Schiffer

The paper uses a mathematical model to show that combining anti-proliferative therapies with ART can lead to a functional cure for HIV within 2-10 years instead of decades.

bioRxiv · Jul 12, 2016Immunology